Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature

BACKGROUND: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastroin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Med Case Rep
Autors principals: Fujii, Yusuke, Hirahara, Noriyuki, Kaji, Syunsuke, Taniura, Takahito, Hyakudomi, Ryoji, Yamamoto, Tetsu, Tajima, Yoshitsugu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870367/
https://ncbi.nlm.nih.gov/pubmed/29580267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-018-1619-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars